Absci Corporation (NASDAQ:ABSI) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Duncan, and I will be your conference operator for today.
Absci Corp (ABSI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 13,726,169 | $41,178,507 | +10% | 0.32% |
| 2. | Redmile Group Jeremy Green | 8,253,316 | $24,759,948 | 1.64% | |
| 3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,300,169 | $9,900,507 | +45% | 0.04% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 2,898,766 | $8,696,298 | +823% | 0.01% |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,134,803 | $6,404,409 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.36 | 37,453 | $200,748.08 | 232,308 | 2026-05-13 | Filing | |
| $2.29 | 100,000 | $229,000.00 | 421,446 | 2026-03-12 | Filing | |
| $2.74 | 75,095 | $205,760.30 | 189,055 | 2026-02-27 | Filing | |
| $3.72 | 40,000 | $148,800.00 | 63,320 | 2025-12-05 | Filing | |
| $2.66 | 95,785 | $254,788.10 | 113,960 | 2025-09-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.99 | 26,761 | $80,015.39 | 8,334,567 | 2026-02-02 | Filing | |
| $2.99 | 17,496 | $52,313.04 | 383,538 | 2026-02-02 | Filing | |
| $4.98 | 19,859 | $98,891.86 | 384,751 | 2024-06-13 | Filing | |
| $4.40 | 3,100,000 | $13,640,000.00 | 11,279,522 | 2024-05-22 | Filing | |
| $1.44 | 40,439 | $58,248.34 | 14,379,522 | 2023-11-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,550,997 | $67,652,991 | 0% | |
| 2. | 11,255,194 | $33,765,582 | 0% | |
| 3. | 7,324,858 | $21,974,574 | 0% | |
| 4. | 5,886,640 | $17,659,920 | 0% | |
| 5. | 5,714,285 | $17,142,855 | 9.83% |
News See All
9 Best Biotech Penny Stocks to Buy in 2026
On April 24, Drew Pettit, Citi US equity strategist, joined 'The Exchange' on CNBC to discuss the market fundamentals this year, with a positive outlook for the market as investors look past geopolitical...
10 Most Shorted Penny Stocks to Buy
In this article, we will take a look at some of the most shorted penny stocks that currently appear highly attractive with impressive upside potential.
Absci Corporation (NASDAQ:ABSI) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Absci Corporation fourth quarter and full year 2025 business update conference call.
Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials
Absci Corporation (NASDAQ:ABSI) is one of the best penny stocks to buy in 2026.
10 Best Penny Stocks to Buy for 2026
A rally in large-cap growth stocks was the catalyst behind US equities powering to record highs in 2025.
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment
Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy according to analysts.
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial
Absci Corporation (NASDAQ:ABSI) announced on December 4, 2025, that the first healthy volunteers had been dosed in the Phase 1/2a HEADLINE clinical trial investigating ABS-201, an experimental anti-prolactin...
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.